Russian government to start inspections of foreign drug manufacturers supplying products to Russia

16 December 2015
moscow-big

The Russian government will start inspections of foreign drug manufacturers supplying their products to Russia starting from next year, in accordance with a recent decree signed by Russia’s Prime Minister Dmitry Medvedev.

That means that Russian inspectors will visit production facilities of all the importers of drugs to Russia, regardless their location, reports The Pharma Letter’s local correspondent.

According to an official spokesman for Veronika Skvortsova, Russia’s Minister of Health, those importers who have not passed the procedure within certain periods may lose the right to export their drugs to Russia. The planned inspections are expected to be conducted on regular basis - once every three years and will be fully comply with global standards.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Pharmaceutical